Condition Lookup

Herpetic Whitlow

Symptoms:
painful vesicles on fingers or hands; swelling; redness; fever; lymphadenopathy

Root Cause:
Infection with herpes simplex virus (HSV-1 or HSV-2) through direct contact with infected lesions.

How it's Diagnosed: videos
Clinical evaluation, Tzanck smear, or PCR testing.

Treatment:
Antiviral medications and supportive care.

Medications:
Acyclovir , Valacyclovir , or Famciclovir (antiviral agents).

Prevalence: How common the health condition is within a specific population.
Common among healthcare workers and those exposed to oral or genital herpes.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Direct contact with HSV lesions, immunosuppression.

Prognosis: The expected outcome or course of the condition over time.
Resolves with treatment; recurrence is possible.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Secondary bacterial infection, recurrence, pain, and difficulty in hand use.

Adenovirus

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fever; sore throat; conjunctivitis (pink eye); respiratory symptoms (cough, runny nose); gastrointestinal symptoms (diarrhea, vomiting); urinary symptoms in severe cases (hemorrhagic cystitis)

Root Cause:
Caused by adenoviruses, which are non-enveloped DNA viruses that can infect various tissues, leading to respiratory, gastrointestinal, and ocular symptoms.

How it's Diagnosed: videos
Clinical evaluation, PCR testing of bodily fluids (e.g., throat swabs, stool samples), viral culture, or antigen detection.

Treatment:
Supportive care, including hydration, antipyretics for fever, and symptomatic management. Severe cases may require antiviral therapy.

Medications:
In severe cases, cidofovir (a nucleotide analog antiviral) may be used. This medication is classified as an antiviral agent.

Prevalence: How common the health condition is within a specific population.
Common; adenovirus infections are widespread and account for approximately 5-10% of respiratory infections in children and various other conditions in adults.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Young age, immunosuppression, crowded living conditions, close contact with infected individuals.

Prognosis: The expected outcome or course of the condition over time.
Generally good for healthy individuals; immunocompromised patients are at higher risk for severe complications.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Bronchitis, pneumonia, encephalitis, keratoconjunctivitis, and disseminated infection in immunocompromised individuals.

Arenaviruses

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fever; headache; myalgia; nausea; vomiting; hemorrhagic symptoms in severe cases

Root Cause:
Caused by arenaviruses, which are RNA viruses transmitted through rodent hosts. Some species can cause hemorrhagic fevers.

How it's Diagnosed: videos
PCR testing, serological testing, and virus isolation in specialized laboratories.

Treatment:
Supportive care; ribavirin (an antiviral medication) may be used in some cases.

Medications:
Ribavirin , an antiviral agent classified as a nucleoside analog.

Prevalence: How common the health condition is within a specific population.
Rare but can occur in endemic regions where rodent reservoirs are prevalent.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Exposure to infected rodents, living in endemic areas, poor sanitation.

Prognosis: The expected outcome or course of the condition over time.
Depends on the specific arenavirus; Lassa fever has a case fatality rate of 1-15%. Early treatment improves outcomes.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Hemorrhagic fever, multi-organ failure, and death in severe cases.

Avian Influenza (Bird Flu)

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
high fever; cough; difficulty breathing; muscle aches; conjunctivitis; diarrhea; neurological symptoms in severe cases

Root Cause:
Caused by avian influenza viruses, primarily H5N1 and H7N9 subtypes, transmitted from infected birds to humans.

How it's Diagnosed: videos
PCR testing, viral culture, or antigen detection from respiratory specimens.

Treatment:
Antiviral medications like oseltamivir or zanamivir. Supportive care may include oxygen therapy or mechanical ventilation in severe cases.

Medications:
Oseltamivir (Tamiflu ) and zanamivir (Relenza ), which are neuraminidase inhibitors classified as antiviral agents.

Prevalence: How common the health condition is within a specific population.
Sporadic; occurs in regions with close contact between humans and infected birds.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Contact with infected poultry, live bird markets, and poor biosecurity measures.

Prognosis: The expected outcome or course of the condition over time.
High mortality rate, especially in H5N1 cases (about 60% case fatality rate). Early treatment improves outcomes.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Acute respiratory distress syndrome (ARDS), multi-organ failure, and death.

B Virus (Macacine Herpesvirus 1, Herpes B)

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fever; chills; muscle aches; lesions at the exposure site; neurological symptoms (headache, confusion, ataxia)

Root Cause:
A rare zoonotic infection transmitted from macaque monkeys, caused by herpesvirus simiae.

How it's Diagnosed: videos
PCR testing of lesion samples or cerebrospinal fluid, serological testing.

Treatment:
Antiviral therapy with acyclovir, valacyclovir, or ganciclovir; immediate wound cleaning is critical.

Medications:
Acyclovir , valacyclovir , and ganciclovir ; these are classified as antiviral agents targeting herpesviruses.

Prevalence: How common the health condition is within a specific population.
Extremely rare; mostly reported in individuals handling macaques in research or zoos.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Monkey bites, scratches, or exposure to infected bodily fluids.

Prognosis: The expected outcome or course of the condition over time.
Potentially fatal if untreated; timely antiviral therapy can be life-saving.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Encephalitis, permanent neurological damage, and death.

Bocavirus

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
respiratory symptoms (cough, wheezing, runny nose); fever; gastrointestinal symptoms (diarrhea, vomiting); possible acute respiratory distress in severe cases

Root Cause:
Caused by human bocaviruses, part of the Parvoviridae family, typically infecting the respiratory and gastrointestinal tracts.

How it's Diagnosed: videos
PCR testing of respiratory secretions or stool samples; serological tests in research settings.

Treatment:
Supportive care, including hydration, antipyretics, and oxygen therapy if required.

Medications:
No specific antiviral medications; treatment is supportive.

Prevalence: How common the health condition is within a specific population.
Common in children; responsible for 5-10% of respiratory infections in hospitalized pediatric patients.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Young age, immunosuppression, and pre-existing respiratory conditions.

Prognosis: The expected outcome or course of the condition over time.
Good in healthy individuals; severe cases can occur in immunocompromised patients.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Pneumonia, bronchiolitis, and prolonged illness in immunocompromised hosts.

Bowenoid Papulosis

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
reddish-brown or flesh-colored lesions on the genitals; asymptomatic or mild itching; sometimes tender lesions

Root Cause:
Caused by certain strains of human papillomavirus (HPV), particularly high-risk types like HPV-16, leading to changes in skin cells resembling carcinoma in situ.

How it's Diagnosed: videos
Diagnosed via clinical examination, dermoscopy, and confirmed with a biopsy showing histopathological features like koilocytosis and dysplasia.

Treatment:
Topical treatments (imiquimod or 5-fluorouracil), cryotherapy, laser ablation, or surgical excision; regular monitoring for malignancy.

Medications:
Topical imiquimod (an immune response modifier) or 5-fluorouracil (a topical chemotherapeutic agent) are commonly prescribed.

Prevalence: How common the health condition is within a specific population.
Rare condition, more common in sexually active individuals with high-risk HPV exposure.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
HPV infection, unprotected sexual activity, multiple sexual partners, immunosuppression.

Prognosis: The expected outcome or course of the condition over time.
Generally benign, but there is a risk of progression to squamous cell carcinoma if untreated.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Potential progression to invasive squamous cell carcinoma or persistent lesions despite treatment.

Viral Hemorrhagic Fevers (VHFs)

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fever; fatigue; muscle aches; bleeding from mucosal surfaces; hypotension; multi-organ failure

Root Cause:
Caused by a group of viruses (e.g., Ebola, Marburg, Lassa, Crimean-Congo hemorrhagic fever) leading to vascular instability and coagulopathy.

How it's Diagnosed: videos
Diagnosed via clinical history, serology (ELISA), PCR, and viral culture; biosafety precautions are critical during testing.

Treatment:
Supportive care (fluid replacement, oxygen therapy), antivirals like ribavirin for specific types (e.g., Lassa fever); experimental treatments may be used for others (e.g., monoclonal antibodies for Ebola).

Medications:
Ribavirin (antiviral for Lassa fever) and monoclonal antibodies like Inmazeb (antibodies for Ebola virus).

Prevalence: How common the health condition is within a specific population.
Regional outbreaks in endemic areas; specific prevalence varies by virus and location.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Exposure to infected animals or humans, travel to endemic areas, healthcare work without adequate PPE.

Prognosis: The expected outcome or course of the condition over time.
High mortality rates (up to 90% for some viruses like Ebola) without treatment; early supportive care improves outcomes.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Organ failure, shock, disseminated intravascular coagulation (DIC), long-term sequelae like fatigue or neurological symptoms.

Chickenpox (Varicella)

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fever; itchy rash that progresses from macules to papules to vesicles and crusts; fatigue; loss of appetite

Root Cause:
Caused by varicella-zoster virus (VZV), leading to a primary systemic infection.

How it's Diagnosed: videos
Clinically diagnosed based on the characteristic rash; PCR or serology may confirm uncertain cases.

Treatment:
Supportive care (antihistamines, acetaminophen for fever); antiviral medications like acyclovir for severe cases or immunocompromised patients.

Medications:
Acyclovir (antiviral inhibiting viral DNA synthesis), valacyclovir (prodrug of acyclovir ), and famciclovir (antiviral).

Prevalence: How common the health condition is within a specific population.
Common worldwide before vaccination; significantly reduced in vaccinated populations.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Lack of vaccination, exposure to infected individuals, immunosuppression.

Prognosis: The expected outcome or course of the condition over time.
Self-limited in healthy individuals; complications more likely in adults or immunocompromised patients.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Secondary bacterial infections, pneumonia, encephalitis, and, later in life, reactivation as shingles.

Chikungunya Virus Infection

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fever; severe joint pain; rash; headache; nausea

Root Cause:
Caused by Chikungunya virus, transmitted by Aedes mosquitoes, leading to systemic inflammation and viral replication.

How it's Diagnosed: videos
Diagnosed via PCR, serology (IgM/IgG antibodies), or viral culture.

Treatment:
Symptomatic treatment with NSAIDs, hydration, and rest; no specific antiviral available.

Medications:
NSAIDs like ibuprofen or acetaminophen for pain and fever.

Prevalence: How common the health condition is within a specific population.
Endemic in tropical and subtropical regions; outbreaks reported globally due to travel and mosquito spread.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Living in or traveling to endemic areas, exposure to mosquito bites, lack of vector control measures.

Prognosis: The expected outcome or course of the condition over time.
Generally self-limiting; joint pain may persist for months.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Chronic arthritis, encephalitis, myocarditis, and rarely death in vulnerable populations.

Cytomegalovirus (CMV)

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fever; fatigue; sore throat; swollen glands; jaundice; muscle aches

Root Cause:
CMV is a herpesvirus that establishes lifelong latent infection and can reactivate, especially in immunocompromised individuals.

How it's Diagnosed: videos
CMV DNA PCR, antigenemia assay, and tissue biopsy with characteristic histopathological findings.

Treatment:
Antiviral therapy for symptomatic or immunocompromised patients. Supportive care for mild cases.

Medications:
Ganciclovir and valganciclovir (antiviral agents). Foscarnet or cidofovir may be used for resistant cases.

Prevalence: How common the health condition is within a specific population.
Approximately 50–80% of adults worldwide are seropositive for CMV.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Immunosuppression (e.g., organ transplantation, HIV), close contact with infected bodily fluids, congenital infection.

Prognosis: The expected outcome or course of the condition over time.
Good for immunocompetent individuals; potentially severe in immunocompromised patients.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Congenital CMV, CMV retinitis, pneumonitis, hepatitis, and gastrointestinal ulcers.

Cytomegalovirus (CMV) Retinitis

Specialty: Infectious Diseases

Category: Viral Infections

Sub-category: Ophthalmologic Complications

Symptoms:
blurry vision; floaters; loss of peripheral vision; blind spots; progressive vision loss

Root Cause:
CMV infection of the retina, leading to retinal necrosis and scarring, primarily affecting immunocompromised individuals.

How it's Diagnosed: videos
Ophthalmologic examination (fundoscopy) revealing characteristic retinal changes, confirmed by CMV DNA PCR in blood or vitreous fluid.

Treatment:
Intravitreal antiviral injections and systemic antiviral therapy to control CMV.

Medications:
Ganciclovir (intravitreal or intravenous), valganciclovir (oral), foscarnet (intravenous for resistant cases).

Prevalence: How common the health condition is within a specific population.
Common among patients with AIDS or other immunosuppressive conditions, particularly with CD4 counts below 50 cells/micro L.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Advanced HIV/AIDS, organ transplantation, immunosuppressive therapy.

Prognosis: The expected outcome or course of the condition over time.
Poor without treatment; blindness can occur. With timely therapy, vision can be preserved in some cases.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Retinal detachment, blindness, and secondary infections.

Epstein-Barr Virus (EBV) Infectious Mononucleosis

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
fatigue; fever; sore throat; swollen lymph nodes; splenomegaly; rash

Root Cause:
EBV infection targets B lymphocytes, causing an immune response that leads to widespread inflammation and systemic symptoms.

How it's Diagnosed: videos
Monospot test, EBV serology (antibody testing), complete blood count (CBC) with atypical lymphocytosis.

Treatment:
Supportive care (hydration, rest, antipyretics). Corticosteroids in severe cases of airway obstruction.

Medications:
No specific antiviral therapy; symptomatic treatment includes NSAIDs like ibuprofen or acetaminophen for fever and sore throat.

Prevalence: How common the health condition is within a specific population.
Affects 90–95% of the global population at some point in life; symptomatic mono occurs primarily in adolescents and young adults.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Close contact with infected individuals, immunosuppression, and young age (15–25 years).

Prognosis: The expected outcome or course of the condition over time.
Excellent in most cases, with symptoms resolving within 2–4 weeks; fatigue may persist longer.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Splenic rupture, secondary bacterial infections, autoimmune hemolytic anemia, and rarely, lymphoma.

Erythema Infectiosum

Specialty: Infectious Diseases

Category: Viral Infections

Sub-category: Childhood Exanthems

Symptoms:
slapped-cheek facial rash; low-grade fever; joint pain or swelling; fatigue; lace-like rash on the body

Root Cause:
Parvovirus B19 infects red blood cell precursors, causing transient aplastic crises in certain individuals.

How it's Diagnosed: videos
Clinical presentation, parvovirus B19 IgM and IgG antibody testing, and PCR for viral DNA.

Treatment:
Supportive care, including antipyretics and hydration; blood transfusion in severe anemia.

Medications:
NSAIDs (e.g., ibuprofen for joint symptoms). Immunoglobulin therapy in immunocompromised individuals.

Prevalence: How common the health condition is within a specific population.
Common in children, with outbreaks in schools; seroprevalence increases with age.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Close contact with infected individuals, underlying hemolytic disorders, or pregnancy.

Prognosis: The expected outcome or course of the condition over time.
Self-limiting in most cases; excellent prognosis.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Fetal hydrops in pregnant women, chronic anemia in immunocompromised individuals.

Herpes Simplex

Specialty: Infectious Diseases

Category: Viral Infections

Symptoms:
painful blisters or sores around the mouth or genitals; itching or tingling sensations; fever; swollen lymph nodes; pain during urination (genital hsv)

Root Cause:
Caused by the Herpes Simplex Virus (HSV), primarily HSV-1 (oral herpes) and HSV-2 (genital herpes). The virus infects nerve cells and establishes latency, reactivating under certain conditions.

How it's Diagnosed: videos
Diagnosis is through clinical examination, polymerase chain reaction (PCR) testing, viral culture, or serology for HSV antibodies.

Treatment:
Antiviral therapy to reduce symptoms and frequency of outbreaks; suppressive therapy for recurrent cases.

Medications:
Antiviral medications such as acyclovir (a nucleoside analog), valacyclovir (a prodrug of acyclovir ), and famciclovir (a guanosine analog). These drugs reduce viral replication and alleviate symptoms.

Prevalence: How common the health condition is within a specific population.
Approximately two-thirds of the global population under 50 years old have HSV-1, and 11% have HSV-2.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Unprotected sexual contact, sharing personal items (e.g., razors, towels), weakened immune systems, and contact with infected individuals.

Prognosis: The expected outcome or course of the condition over time.
Lifelong infection with periodic outbreaks; symptoms can be managed with treatment, and suppressive therapy can reduce recurrence and transmission risk.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Severe infections in immunocompromised individuals, neonatal herpes, herpetic keratitis (eye infection), and increased risk of HIV transmission.

Herpes Simplex Virus (HSV) Empiric Therapy

Specialty: Infectious Diseases

Category: Viral Infections

Sub-category: Therapeutic Approaches

Symptoms:
tingling or itching in areas of potential outbreak; blister formation; pain in affected areas; flu-like symptoms in primary infection

Root Cause:
Rapid initiation of therapy during suspected HSV reactivation is crucial to mitigate outbreak severity and duration.

How it's Diagnosed: videos
Empirical treatment based on patient-reported symptoms and history of outbreaks; confirmed with PCR or serology in uncertain cases.

Treatment:
Early initiation of antiviral therapy upon symptom onset or as suppressive treatment in recurrent cases.

Medications:
Acyclovir , valacyclovir , and famciclovir are commonly prescribed. All are antivirals that inhibit viral DNA polymerase activity.

Prevalence: How common the health condition is within a specific population.
HSV is widespread; empiric therapy targets individuals with recurrent symptoms or known exposure.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Recurrent HSV infections, immunosuppression, and frequent triggers like stress or illness.

Prognosis: The expected outcome or course of the condition over time.
Improves with timely treatment; reduces symptom duration and recurrence frequency.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Delayed treatment may lead to more severe outbreaks or complications like herpetic neuralgia.

Herpes Simplex Virus (HSV) Keratitis

Specialty: Infectious Diseases

Category: Viral Infections

Sub-category: Ocular Infections

Symptoms:
eye pain; redness; blurred vision; sensitivity to light; tearing; eye discharge; foreign body sensation in the eye

Root Cause:
HSV infection of the cornea, leading to inflammation and potential damage to the eye's surface. The virus can remain dormant in the trigeminal ganglion and reactivate, affecting the eye.

How it's Diagnosed: videos
Diagnosed through clinical examination, fluorescein staining, slit-lamp examination, PCR testing, and viral cultures.

Treatment:
Antiviral treatment, either topical or systemic, along with corticosteroids (in some cases) to control inflammation.

Medications:
Topical acyclovir (an antiviral), oral valacyclovir , and famciclovir (oral antivirals), often in combination with corticosteroids like prednisolone to reduce inflammation.

Prevalence: How common the health condition is within a specific population.
HSV keratitis is the leading cause of infectious blindness in the developed world.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Previous ocular HSV infection, immunocompromised status, and trauma to the eye.

Prognosis: The expected outcome or course of the condition over time.
With early treatment, the prognosis is generally good, but repeated infections can lead to scarring and vision loss.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Corneal scarring, glaucoma, and, in severe cases, permanent vision loss if untreated.

Human Cowpox Infection

Specialty: Infectious Diseases

Category: Viral Infections

Sub-category: Zoonotic Infections

Symptoms:
skin lesions; fever; headache; muscle aches; fatigue; swollen lymph nodes; blistering rash

Root Cause:
Infection with the cowpox virus, a zoonotic poxvirus primarily transmitted from animals (particularly rodents or cats) to humans through direct contact.

How it's Diagnosed: videos
Diagnosis is based on clinical presentation and confirmed with PCR or viral culture of the lesion.

Treatment:
Symptomatic treatment; in severe cases, antiviral drugs like tecovirimat (a smallpox drug) may be used.

Medications:
Tecovirimat (a drug used to treat orthopoxvirus infections like smallpox and cowpox) and cidofovir (an antiviral). Supportive care may include analgesics and wound care.

Prevalence: How common the health condition is within a specific population.
Rare, with most cases occurring in people with direct contact with infected animals.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Animal exposure, particularly handling infected rodents or pets with cowpox lesions.

Prognosis: The expected outcome or course of the condition over time.
Generally self-limiting, with most people recovering fully; however, complications can arise if untreated.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Secondary bacterial infections, scarring, or prolonged skin lesions in immunocompromised individuals.

Human Herpesvirus 6 (HHV-6) Infection

Specialty: Infectious Diseases

Category: Viral Infections

Sub-category: Herpesviridae Infections

Symptoms:
fever; rash (roseola); irritability; diarrhea; swollen lymph nodes; febrile seizures

Root Cause:
HHV-6 infection is caused by a virus that commonly infects infants and young children. It can cause roseola, a rash after fever, and may also be linked to certain neurological and autoimmune disorders.

How it's Diagnosed: videos
Diagnosis is typically based on clinical presentation, supported by PCR testing for viral DNA.

Treatment:
Symptomatic treatment for fever and seizures; antiviral medications may be used in severe cases.

Medications:
Ganciclovir and valganciclovir are antiviral medications that may be used for severe HHV-6 infections, especially in immunocompromised patients.

Prevalence: How common the health condition is within a specific population.
Almost all individuals are infected with HHV-6 by the age of 2; it causes roseola in infants and can persist as a latent infection.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Age (infants are most affected), immunocompromised states (such as organ transplants or HIV/AIDS).

Prognosis: The expected outcome or course of the condition over time.
Generally good in healthy children; complications arise in immunocompromised individuals.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Febrile seizures, encephalitis, and autoimmune diseases in rare cases.

Human Papillomavirus (HPV)

Specialty: Infectious Diseases

Category: Viral Infections

Sub-category: Oncogenic Infections

Symptoms:
genital warts; itching or discomfort in genital area; abnormal pap smear; throat or mouth lesions in oral hpv

Root Cause:
HPV is a group of viruses, some of which are oncogenic and can lead to cancers such as cervical, anal, and oropharyngeal cancers. HPV is transmitted through direct skin-to-skin or sexual contact.

How it's Diagnosed: videos
Diagnosis is made through physical examination, biopsy of suspicious lesions, and Pap smears for cervical HPV. HPV typing can be done through PCR or hybrid capture tests.

Treatment:
Warts can be treated with cryotherapy, laser therapy, or topical treatments; however, no cure exists for the virus itself.

Medications:
Topical imiquimod (an immune response modifier), podophyllin (a plant-derived compound ), or sinecatechins for genital warts.

Prevalence: How common the health condition is within a specific population.
Over 80% of sexually active individuals are infected with HPV at some point in their lives.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Unprotected sexual activity, multiple sexual partners, immunocompromised conditions, and smoking.

Prognosis: The expected outcome or course of the condition over time.
Many HPV infections clear spontaneously within 1-2 years; however, persistent infection with high-risk strains can lead to cancer.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Cervical cancer, anal cancer, and oropharyngeal cancer, as well as the potential for genital warts.